Evaluation of psoriasis patients’ attitudes toward benefit–risk and therapeutic trade-offs in their choice of treatments

References

• DubertretLMrowietzURankiAEuropean patient perspectives on the impact of psoriasis: the EUROPSO patient membership surveyBr J Dermatol2006155472973616965422
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical ExcellencePsoriasis: Assessment and Management. Clinical Guideline No 153London, UKNational Institute for Health and Clinical Excellence2012
   Google Scholar
• ChoiJKooJYQuality of life issues in psoriasisJ Am Acad Dermatol200349Suppl 2S57S6112894127
   PubMed Web of Science ®Google Scholar
• SampognaFTabolliSSoderfeldtBAxteliusBAparoUAbeniDMeasuring quality of life of patients with different clinical types of psoriasis using the SF-36Br J Dermatol2006154584484916634884
   PubMed Web of Science ®Google Scholar
• AltobelliEPetrocelliRMaccaroneMRisk factors of hypertension, diabetes and obesity in Italian psoriasis patients: a survey on socio-demographic characteristics, smoking habits and alcohol consumptionEur J Dermatol200919325225619220983
   PubMed Web of Science ®Google Scholar
• FarleyEMenterAPsoriasis: comorbidities and associationsG Ital Dermatol Venereol2011146191521317853
   PubMed Web of Science ®Google Scholar
• MenterAGottliebAFeldmanSRGuidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologicsJ Am Acad Dermatol200858582685018423260
   PubMed Web of Science ®Google Scholar
• GriffithsCEClarkCMChalmersRJLi Wan PoAWilliamsHCA systematic review of treatments for severe psoriasisHealth Technol Assess20004401125
   PubMedGoogle Scholar
• NickoloffBJNestleFORecent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunitiesJ Clin Invest2004113121664167515199399
   PubMed Web of Science ®Google Scholar
• PathiranaDOrmerodADSaiagPEuropean S3-guidelines on the systemic treatment of psoriasis vulgarisJ Eur Acad Dermatol Venereol200923Suppl 2170
   PubMed Web of Science ®Google Scholar
• MenterAKormanNJElmetsCAGuidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusionsJ Am Acad Dermatol201165113717421306785
   PubMed Web of Science ®Google Scholar
• KalbREFiorentinoDFLebwohlMGRisk of serious infection with biologic and systemic treatment of psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)JAMA Dermatol2015151996196925970800
   PubMed Web of Science ®Google Scholar
• FoniaAJacksonKLereunCGrantDMBarkerJNSmithCHA retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasisBr J Dermatol2010163480781620662837
   PubMed Web of Science ®Google Scholar
• FinlayAYKhanGKDermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical useClin Exp Dermatol19941932102168033378
   PubMed Web of Science ®Google Scholar
• KitchenHCordingleyLYoungHGriffithsCEBundyCPatient-reported outcome measures in psoriasis: the good, the bad and the missing!Br J Dermatol201517251210122125677764
   PubMed Web of Science ®Google Scholar
• LebwohlMGBachelezHBarkerJPatient perspectives in the management of psoriasis: results from the population-based multinational assessment of psoriasis and psoriatic arthritis surveyJ Am Acad Dermatol201470587188124576585
   PubMed Web of Science ®Google Scholar
• SternRSNijstenTFeldmanSRMargolisDJRolstadTPsoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfactionJ Investig Dermatol Symp Proc200492136139
   PubMed Web of Science ®Google Scholar
• SmithCHAnsteyAVBarkerJNBritish Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009Br J Dermatol20091615987101919857207
   PubMed Web of Science ®Google Scholar
• BridgesJFHauberABMarshallDConjoint analysis applications in health – a checklist: a report of the ISPOR good research practices for conjoint analysis task forceValue Health201114440341321669364
   PubMed Web of Science ®Google Scholar
• Reed JohnsonFLancsarEMarshallDConstructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task forceValue Health201316131323337210
   PubMed Web of Science ®Google Scholar
• StreetDJBurgessLLouviereJJQuick and easy choice sets: constructing optimal and nearly optimal stated choice experimentsInt J Res Mark2005224459470
   Web of Science ®Google Scholar
• LancsarELouviereJConducting discrete choice experiments to inform healthcare decision making: a user’s guidePharmacoeconomics200826866167718620460
   PubMed Web of Science ®Google Scholar
• BechMGyrd-HansenDEffects coding in discrete choice experimentsHealth Econ200514101079108315852455
   PubMed Web of Science ®Google Scholar
• KaufTLYangJCKimballABPsoriasis patients’ willingness to accept side-effect risks for improved treatment efficacyJ Dermatolog Treat201526650751325946139
   PubMed Web of Science ®Google Scholar
• KromerCSchaarschmidtMLSchmiederAHerrRGoerdtSPeitschWKPatient preferences for treatment of psoriasis with biologicals: a discrete choice experimentPLoS One2015106e012912026058083
   PubMed Web of Science ®Google Scholar
• SchaarschmidtMLSchmiederAUmarNPatient preferences for psoriasis treatments: process characteristics can outweigh outcome attributesArch Dermatol2011147111285129422106115
   PubMedGoogle Scholar
• SestonEMAshcroftDMGriffithsCEBalancing the benefits and risks of drug treatment: a stated-preference, discrete choice experiment with patients with psoriasisArch Dermatol200714391175117917875880
   PubMedGoogle Scholar
• UmarNYamamotoSLoerbroksATerrisDElicitation and use of patients’ preferences in the treatment of psoriasis: a systematic reviewActa Derm Venereol201292434134622278662
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care ExcellenceNICE pathways: Psoriasis overview2016 Available from: https://pathways.nice.org.uk/pathways/psoriasisAccessed November 21, 2016
   Google Scholar
• HodgkinsPSwinburnPSolomonDYenLDewildeSLloydAPatient preferences for first-line oral treatment for mild-to-moderate ulcerative colitis: a discrete-choice experimentPatient201251334422077619
   PubMedGoogle Scholar
• LloydAMcIntoshEPriceMThe importance of drug adverse effects compared with seizure control for people with epilepsy: a discrete choice experimentPharmacoeconomics200523111167118116277551
   PubMed Web of Science ®Google Scholar
• LloydAMcIntoshEWilliamsAEKapteinARabeKFHow does patients’ quality of life guide their preferences regarding aspects of asthma therapy? A patient-preference study using discrete-choice experiment methodologyPatient20081430931622272998
   PubMedGoogle Scholar
• Center for Devices and Radiological HealthFactors to consider when making benefit-risk determinations in medical device premarket approval and de novo classifications2012 Available from: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM296379.pdfAccessed June 8, 2016
   Google Scholar
• HoMPGonzalezJMLernerHPIncorporating patient-preference evidence into regulatory decision makingSurg Endosc201529102984299325552232
   PubMed Web of Science ®Google Scholar
• LernerHWhangJNipperRBenefit-risk paradigm for clinical trial design of obesity devices: FDA proposalSurg Endosc201327370270723247746
   PubMed Web of Science ®Google Scholar
• CleemputIDevrieseSKohnLIncorporating societal preferences in reimbursement decisions – relative importance of decision criteria according to Belgian citizens2014 Available from: https://kce.fgov.be/sites/default/files/page_documents/KCE_234_reimbursement_decisions_Report_0.pdfAccessed June 8, 2016
   Google Scholar
• Centers for Medicare and Medicaid ServicesMedicare program; hospital inpatient value-based purchasing program. Final ruleFed Regist20117688264902654721548401
   PubMedGoogle Scholar
• ThokalaPDuenasAMultiple criteria decision analysis for health technology assessmentValue Health20121581172118123244821
   PubMed Web of Science ®Google Scholar
• UnderwoodGNICE to research patient preferences in HTA2016 Available from: http://www.pharmatimes.com/news/nice_to_research_patient_preferences_in_hta_1033029Accessed June 8, 2016
   Google Scholar
• IskandarIYAshcroftDMWarrenRBDemographics and disease characteristics of patients with psoriasis enrolled in the British association of dermatologists biologic interventions registerBr J Dermatol2015173251051825989336
   PubMed Web of Science ®Google Scholar
• YeungHTakeshitaJMehtaNNPsoriasis severity and the prevalence of major medical comorbidity: a population-based studyJAMA Dermatol2013149101173117923925466
   PubMed Web of Science ®Google Scholar
• TakeshitaJWangSShinDBEffect of psoriasis severity on hypertension control: a population-based study in the United KingdomJAMA Dermatol2015151216116925322196
   PubMed Web of Science ®Google Scholar